A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
批准号:
3837914
负责人:
C NATANSON
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
While live bacteria commonly cause infection, the relative role of
bacterial toxins versus live bacteria to produce morbidity and mortality is
not known, if bacterial toxins are important factors, therapies directed at
these toxins may be required. Even if no bacteria remain alive or grow,
these preformed toxins may be important in determining morbidity and
mortality. Therapies directed at these toxin may be important additions to
antibiotic therapy.
Using two E. coli in the canine model, we designed a study to determine
whether organism virulence factors or bacterial toxins were more important
in producing septic shock. Measures of hemodynamic shock, blood cultures,
endotoxin levels and survival were done serially with both organisms live,
both organisms killed, and with purified endotoxin from these organisms.
Approximately 4 man years have gone into this study. Preliminary results
from this study have been presented at the American Federation of Clinical
Research and the Society of Critical Care Medicine. This presentation won
a poster award in 1990. There has been much interest in these data as
determination of the factors that produce morbidity in infection will guide
trials for future therapies of children and adults with septic shock.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USE OF A SELECTIVE BRADYKININ ANTAGONIST IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:5201091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:6161407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3896256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
NITRIC OXIDE SYNTHASE INHIBITORS IN VIVO TNF-INDUCED MYOCARDIAL DEPRESSION
-
批准号:3752179
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3774439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
MYOCARDIAL METABOLISM IN A CANINE MODEL OF HUMAN BACTERIAL SEPSIS
-
批准号:3774436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3874266
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:3853021
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CONTROLLED TRIAL OF TYROSINE KINASE INHIBITORS IN CANINE MODEL OF SEPTIC SHOCK
-
批准号:2456661
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CARDIOPULMONARY PATHOPHYSIOLOGY IN CANINE SEPTIC SHOCK
-
批准号:3916459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:5201066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3752157
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
BACTERICIDAL-PERMEABILITY INCREASING PROTEIN IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:3752182
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3837938
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3853060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3853034
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CATHECOLAMINE THERAPY IN CANINE SEPTIC SHOCK
-
批准号:3916437
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ENDOGENOUS MEDIATORS IN THE PATHOPHYSIOLOGY OF CANINE SEPTIC SHOCK
-
批准号:3916436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CANINE MODEL OF SEPTIC SHOCK
-
批准号:3963111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
RECONSTITUTED HIGH-DENSITY LIPOPROTEINS IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:5201090
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
海外基金